Abstract
Background: nCOVID-19 is portrayed by obvious fluctuations in terms of symptomatic severity. Recently, 25-(OH)-D has been suggested as a potential factor in determining nCOVID-19 severity. This survey aimed to study the relationship between serum level of 25-hydroxyvitamin-D (25-(OH)-D) and nCOVID-19 severity. Methodology: A hospital-based electronic information approach was utilized at Najran Hospitals for ten months. Participants were nCOVID-19 diagnosed patients. Subjects' demographic characteristics and clinical outcomes were obtained from the hospitals' electronic records. Results: 134 subjects' electronic data were obtained and used in the current survey. The mean age of the sample was 41.6±13.9; among them, 71(53%) were males. 91(67.9%) of the studied subjects were either asymptomatic or had mild symptoms that refer to the group (1). At the same time, 43(32.1%) were nCOVID-19 severely ill cases and had been admitted to ICUs who were group (2). Prevalence of serum 25-(OH)-D Deficiency, Insufficiently, and Adequate according to gender (females vs. males) was (32% vs. 16%), (42% vs. 22%) and (25% vs. 62%) respectively. A statistically significant difference was observed in gender and mean age regarding nCOVID-19 severity. Moreover, a significant difference was noticed between the mean± SD of serum 25-[OH]-D levels among the two groups were 38.66 ±12.9 vs. 32.09± 9.57) in favor of group 1. Conclusion: Our findings revealed that sera 25-(OH)-D is potentially correlated with the severity of the nCOVID-19 pandemic.
References
References
WHO, CORONA VIRUS PANDEMIC: last updated on March 9th, 2020. Retrieved from the following website, December 9th, 2021 at 12:22 pm
https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1
Richardson S, Hirsch JS, Narasimhan et al.: Horthwell COVID-19. Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in New Yprk City area. JAMA. 2020; 323(20):2052-2059.
Haleem A, Javaid M, and Vaishya: Effects of COVID-19 pandemic in daily life. Curr Med Res Pract. 2020; 10(2): 78-79.
Pfefferbaum B, and North CS: Mental health and the COVID-19 pandemic. N Engl J Med. 2020; 383(6): 510-512
WHO: Coronavirus disease (COVID-19): Variants of SARS-COV-2; December; 2021. Retrieved from the following website: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease%28covid-19%29-variants-of-sars-cov-2?gclid=EAlalQobChMI8ofE8rfM9QIVJYIoCR23iA6REAMYASAAgIFBfD_BwE
Kim GU, Kim MJ, Ra SH. et al. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19. Clin Microbiol Infect. 2020; 26(1): 948-948.
Al Mutair A, AlHumaid S, AlHuqban W. et al: Clinical, epidemiological, and laboratory characteristics of mild-to- moderate COVID-19 patients in Saudi Arabia: An observational cohort study. Eur J Med Res. 2020; 25(61):1-8.
Arentz M, Yim E, Klaff L et al: Characteristics and outcomes of 21 Critically ill patients with COVID-19 in Washington State. JAMA. 2020; 323(16):1612-4.
Huang C, Wang Y, and Li X: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506.
Chen G, Wu D, Guo W. et al: Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(1): 2620-9.
Forrest KY, and Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011; 31(1): 48-54.
Weir EK, Thenappan T, Bhargava M, and Chen y: Does vitamin D deficiency increase the severity of COVID-19?. Clin Med (Lond). 2020; 20(4): 107-108.
Holick MF: Vitamin D deficiency. N Engl J Med. 2007; 357(3): 266-281.
Kennel KA, Drake MT, and Hurley DL: Vitamin D deficiency in adults: When to test and how to treat. Mayo Clin Proc. 2010; 85(8): 752-757.
Pal R, Banerjee M, Bhadada SK, Shetty J, Singh B, and Vyas A.: Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis. J Endocrinol Invest. 2021; 24: 1-16.
Fisher SA, Rahimzadeh M, and Brierley C et al: The role of vitamin D in increasing circulation T-regulatory cell numbers and modulating T-regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: A systematic review, PloS One. 2019; 14(9): e0222313.
Braun A, Chang D, and Mahadevappa K et al.: Association of low serum 25-hydroxyvitamin D levels and morbidity in the critically ill. Crit Care Med. 2011; 39(4): 671-677.
Bikle D D: Vitamin D metabolism, mechanism of action, and clinical applications. Chem. Biol. 2014; 21(3): 319- 329.
Cynthia Aranow: Vitamin- D and the Immune System. J Investig Med. 2011; 59(6): 881 – 886.
Hastie CE, Mackay DF, and Ho F et al: Vitamin D concentrations and COVID-19 infection in UK. Biobank. Diabetes Metab Syndr. 2020; 14(4): 561 – 565.
Xu T, Baylink DJ, Chen CS, Reeves ME et al: The importance of vitamin D metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J Transl Med. 2020; 18(1): 322.
Hewison M: Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am. 2010; 39(2): 365- 79.
DeLuca HF: Vitamin D: Historical overview. Vitam Horm. 2016; 100(1): 1-20.
Institute of Medicine , IOM. Dietary Reference Intakes for calcium and vitamin D. Washington DC: The National Academy Press; 2011. Retrieved from the following website:
Martineau AR, and Forouhi NG: Vitamin D for COVID-19: a case to answer? Lancet Diabetes Endocrinol. 2020; 8(9): 735 -736.
Parekh D, Dancer RCA, and Scott A et al: Vitamin D to prevent lung injury following esophagectomy – a randomized, placebo-controlled trial. Crit Care Med. 2018; 46(12): e1128- e1135.
Teymoori-Rad M, Shokri F, Salimi V, and Marashi SM.: The interplay between vitamin D and viral infections. Rev Med Virol. 2019: 29(2): e2032.
Farid E, Jaradat AA, Al-Segai O, and Hassan AB. Prevalence of Vitamin D Deficiency in Adult Patients with Systemic Lupus Erythematosus in Kingdom of Bahrain Egypt J Immunol 2017; 24(2): 1-8.
Grant WB, Lahore H, McDonnell SL et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020; 12:988.
Pinzon RT, and Angela Pradana AW: Vitamin D deficiency among patients with COVID-19: Case series and recent literature review. Trop Med Health. 2020; 48(1): 102.
Biesalski HK: Vitamin D deficiency and co-morbidities in COVID-19 patients: a fatal relationship? Nfs J. 2020; 20(1): 10-21.
Laird E, Rhodes J. and Kenny RA: Vitamin D and inflammation: Potential implications for severity of COVID-19. Ir. Med. J. 2020; 113(5): 81.
Mendy A, Apewokin S, Wells AA, and Morrow AL.: Factors associated with hospitalization and disease severity in a racially and ethnically diverse population of COVID-19 patients. MedRxiv Prepr. Serv Heal Sci. 2020.
Ricci A, Pagliuca A, and D'Ascanio M. et al: Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients. Respir Res. 2021; 22(1): 76.
Ilie PC, Stefanescu S, and Smith L.: The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020; 32(7): 1195 -1198.
Jain A, Chaurasia R, and Sengar NS et al: Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci Rep 2020; 10(1): 20191.
Singh S, Nimavat N, Kumar Singh A, Ahmad S, and Sinha N.: Prevalence of low level of vitamin D among COVID-19 Patients and Associated Risk Factors in India-A Hospital-Based Study. Int J Gen Med. 2021; 14(1): 2523 – 2531.
Plotnikoff GA, and Quigley JM.: Prevalence of severe hypovitaminosis D in patients with persistent., non-specific musculoskeletal pain. Mayo Clin Proc. 2003; 78(1): 1463- 1470.
Szeto B, Zucker JE, and LaSota ED et al.: Vitamin D status and COVID-19 Clinical Outcomes in Hospitalized Patients. Endoor Res. 2021; 46(2): 166-73.
Rizaldy Taslim Pinzon I, Angela I and Andryawan Wahyu Pradana: Vitamin D deficiency among patients with COVID-19. Case series and recent literature review. Tropical Medicine and Health. 2020; 48:102.